NCT06232239View on ClinicalTrials.gov

Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

April 5, 2024

Study Completion Date

April 19, 2024

Conditions
Healthy Subjects
Interventions
DRUG

Empagliflozin-Test product

Empagliflozin 10 mg tablets Test product Manufactured by: Thai Meiji Pharmaceuticals Co., Ltd., Thailand

DRUG

Empagliflozin-Reference product

Empagliflozin 10 mg tablets Reference product Manufactured by: Boehringer Ingelheim Pharma Gmbh \& Co. Kg, Germany

All Listed Sponsors
lead

Bio-innova Co., Ltd

INDUSTRY

NCT06232239 - Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg | Biotech Hunter | Biotech Hunter